0.61
1.21%
-0.0075
Handel nachbörslich:
.611
0.001
+0.16%
Monopar Therapeutics Inc Aktie (MNPR) Neueste Nachrichten
Bears are Losing Control Over Monopar Therapeutics (MNPR), Here's Why It's a 'Buy' Now - Yahoo Finance UK
Yahoo Finance UK
Bears are Losing Control Over Monopar Therapeutics (MNPR), Here's Why It's a 'Buy' Now - Nasdaq
Nasdaq
Monopar Therapeutics (NASDAQ:MNPR) Receives Buy Rating from HC Wainwright - Defense World
Defense World
Monopar Therapeutics (MNPR) Up On Soft Tissue Sarcoma Study Data - Yahoo New Zealand News
Yahoo New Zealand News
Monopar Therapeutics (MNPR) Catches Eye: Stock Jumps 11.2% - Yahoo Movies Canada
Yahoo Movies Canada
Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline - GlobeNewswire
GlobeNewswire
Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline
GlobeNewswire Inc.
Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline - GlobeNewswire
GlobeNewswire
Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting
GlobeNewswire Inc.
Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging ... - GlobeNewswire
GlobeNewswire
Monopar Announces Filing of Patent Protecting MNPR-101 Radiopharma Optimization Findings - GlobeNewswire
GlobeNewswire
Monopar files patent for cancer imaging agent By Investing.com - Investing.com
Investing.com
Monopar Therapeutics Begins Phase 1 Cancer Imaging Trial - TipRanks.com - TipRanks
TipRanks
Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients
GlobeNewswire Inc.
Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr in Advanced Cancer Patients - Yahoo Finance
Yahoo Finance
Monopar Therapeutics (MNPR) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Zacks Investment Research
All You Need to Know About Monopar Therapeutics (MNPR) Rating Upgrade to Buy
Zacks Investment Research
Monopar Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Developments - GlobeNewswire
GlobeNewswire
MNPR Stock Quote Price and Forecast - CNN
CNN
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Monopar Therapeutics Unveils Radiopharma Advances Online - TipRanks.com - TipRanks
TipRanks
Monopar Therapeutics Unveils Radiopharma Advances Online - TipRanks.com - TipRanks
TipRanks
Monopar Therapeutics Reports Promising MNPR-101 Study Results - TipRanks.com - TipRanks
TipRanks
Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program
GlobeNewswire Inc.
Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program - GlobeNewswire
GlobeNewswire
Monopar Therapeutics Advances Cancer Research with Clinical Trial - TipRanks.com - TipRanks
TipRanks
Thinking about buying stock in Monopar Therapeutics, AMC Entertainment, Zyversa Therapeutics, MoneyHero, or Blink ... - Marketscreener.com
Marketscreener.com
What Causes Penny Stocks to Climb in Price?
PennyStocks
Crude Oil Down 2%; Maravai LifeSciences Shares Spike Higher
Benzinga
Dow Surges Over 150 Points; AerCap Posts Upbeat Earnings
Benzinga
Identifying Trends With Penny Stocks; How to Guide
PennyStocks
5 Best Rising Penny Stocks To Buy - Insider Monkey
Insider Monkey
Dow Gains Over 400 Points; Keurig Dr Pepper Shares Fall After Q4 Results
Benzinga
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
Crude Oil Rises 1%; US Jobless Claims Fall To 201,000
Benzinga
5 Hot Penny Stock On the Move - Insider Monkey
Insider Monkey
3 Rules for Trading Penny Stocks That All Traders Need
PennyStocks
Monopar's radiopharmaceutical cleared to enter phase I in Australia for advanced cancers - BioWorld Online
BioWorld Online
Crude Oil Moves Lower; Summit Therapeutics Shares Plummet
Benzinga
Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Dow Dips Over 100 Points; US Leading Economic Index Falls In January
Benzinga
Nasdaq Down 1%; Capital One Set To Buy Discover
Benzinga
Monopar Therapeutics Advances with Phase 1 Trial Approval - TipRanks.com - TipRanks
TipRanks
Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101 ... - Yahoo Finance
Yahoo Finance
Monopar Therapeutics Inc Reports Q3 2023 Financial Results and Progress in Clinical Programs - Yahoo Finance
Yahoo Finance
Soft Tissue Sarcoma Market to Propel by 2032, Predicts DelveInsight | Key Companies in the Market - Monopar, Jazz ... - GlobeNewswire
GlobeNewswire
Why Is Monopar Therapeutics (MNPR) Stock Down 47% Today? - InvestorPlace
InvestorPlace
Monopar and NorthStar Partner with IsoTherapeutics for the Manufacturing of Potential Therapeutic for Severe COVID-19 - GlobeNewswire
GlobeNewswire
Monopar Therapeutics Rings the Opening Bell - Nasdaq
Nasdaq
MNPR Stock Price and Chart — NASDAQ:MNPR - TradingView
TradingView
Kapitalisierung:
|
Volumen (24h):